U.S. News & World Report Expands Use of Solventum's Ambulatory Potentially Preventable Complications Grouping Software for Use in Its 2024-2025 Best Hospitals Rankings
Rhea-AI Summary
Solventum announced that U.S. News & World Report will expand its use of Solventum's AM-PPCs software in analyzing the 2024-2025 Best Hospitals rankings. The software will now be used in the Ear, Nose & Throat specialty ranking, the Prostate Cancer Surgery rating, and the new Gynecological Cancer Surgery rating.
The AM-PPCs software helps identify potentially preventable complications in outpatient settings. Preliminary analysis shows complication rates can be as high as 13% for certain procedures, affecting patient safety and satisfaction. This expansion aims to improve procedural safety and quality improvement.
Positive
- Expansion of AM-PPCs software use in high-visibility rankings like U.S. News & World Report's Best Hospitals.
- Potential for increased revenue through new applications of the software in multiple medical specialties.
- Preliminary analysis indicates the software's effectiveness in identifying complications, which can improve healthcare quality.
Negative
- High complication rates (up to 13%) identified, indicating a need for significant improvements in outpatient care. Continuous improvements may be required to maintain credibility and effectiveness.
News Market Reaction 1 Alert
On the day this news was published, SOLV gained 0.29%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
"We are excited to support
Developed to address patient safety and quality oversight for procedures performed in hospital outpatient departments or ambulatory surgery centers. It uses sophisticated grouping logic, and enables care providers, government entities, patient safety organizations and payers to identify and analyze potential complications in outpatient settings by specific procedures, service lines, providers and facilities within coding solutions and business intelligence systems. National benchmarks are also included.
Preliminary Solventum analysis of more than 23 million at-risk ambulatory procedures indicates that complication rates may be as high as
"We look forward to our continued work with Solventum to support promoting improved outpatient procedural safety. Although not all complications are preventable, excessive complications can be reduced if they are clearly identified and addressed," said Ben Harder, U.S. News & World Report managing editor and chief of health analysis. "Use of AM-PPCs were further extended this year to inform the Ear, Nose & Throat specialty ranking, as well as the Prostate Cancer Surgery rating and Gynecological Cancer Surgery procedure rating which will help us continue to build on our foundation of patient outcomes measurement in our Best Hospitals rankings."
1Analysis conducted using 3M AM-PPC Methodology and 2019-2022 CMS SAF files representing all Hospital Fee For Service (FFS) claims.
About Solventum
At Solventum (NYSE: SOLV), we enable better, smarter, safer healthcare to improve lives. As a new company with a long legacy of creating breakthrough solutions for our customers' toughest challenges, we pioneer game-changing innovations at the intersection of health, material and data science that change patients' lives for the better — while empowering healthcare professionals to perform at their best. See how at Solventum.com.
About U.S. News & World Report
View original content to download multimedia:https://www.prnewswire.com/news-releases/us-news--world-report-expands-use-of-solventums-ambulatory-potentially-preventable-complications-grouping-software-for-use-in-its-2024-2025-best-hospitals-rankings-302183482.html
SOURCE Solventum